20 March 2024
Court of Justice of European Union Clarifies Impartiality Requirements for Experts Consulted by European Medicines Agency
1 min read
On 14 March 2024, the Court of Justice of the European Union held that the European Medicines Agency (EMA) had breached the impartiality requirements when examining a marketing authorisation for a medicinal product.
On 14 March 2024, the Court of Justice of the European Union held that the European Medicines Agency (EMA) had breached the impartiality requirements when examining a marketing authorisation for a medicinal product. The EMA was also found to have breached its own internal procedural guidelines. The judgment is noteworthy because it overturns an earlier judgment of the General Court which had dismissed the plaintiff’s action.
Please find attached a note discussing this judgment. A link to the judgment is included in the note.
Attachments:
News & insights
2 min
read
read
Briefings
Belgium Publishes Third Annual Report Regarding Screening of Foreign Direct Investment
11 September 2026
10 min
read
read
Briefings
Public procurement rules being set aside in European defence deals
21 September 2026
4 min
read
read
Briefings
Belgian Competition Authority Closes Live Nation / Pukkelpop Investigation on Commitments
21 September 2026
5 min
read
read
Briefings
Urban Wastewater Treatment Directive Remains Focus of Litigation and Parliamentary Activity
15 September 2026
10 min
read
read
Briefings
Belgian Council of State Suspends EUR 750 Million Casino Concession Award on Foreign Subsidies Regulation Grounds: A First for Belgian Public Tendering Litigation
17 September 2026
3 min
read
read
Briefings
Belgian Competition Authority Issues Historic First Decision on Abuse of Economic Dependence
8 September 2026
2 min
read
read
Briefings
Belgium’s Interfederal Screening Committee Issues First-Ever Prohibition of Foreign Direct Investment
10 August 2026
